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Abstract
Microbes are important producers of natural products, which have played key roles in 
understanding biology and treating disease. However, the full potential of microbes to produce 
natural products has yet to be realized; the overwhelming majority of natural product gene clusters 
encoded in microbial genomes remain “cryptic”, and have not been expressed or characterized. In 
contrast to the fast-growing number of genomic sequences and bioinformatic tools, methods to 
connect these genes to natural product molecules are still limited, creating a bottleneck in genome-
mining efforts to discover novel natural products. Here we review developing technologies that 
leverage the power of homologous recombination to directly capture natural product gene clusters 
and express them in model hosts for isolation and structural characterization. Although direct 
capture is still in its early stages of development, it has been successfully utilized in several 
different classes of natural products. These early successes will be reviewed, and the methods will 
be compared and contrasted with existing traditional technologies. Lastly, we will discuss the 
opportunities for the development of direct capture in other organisms, and possibilities to 
integrate direct capture with emerging genome-editing techniques to accelerate future study of 
natural products.
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1. INTRODUCTION
Natural products have revolutionized modern medicine. Between the 1940s and 1960s, 
natural products of diverse structures and biological activities were frequently isolated from 
microbial cultures and transformed into life-saving pharmaceuticals, including antibiotics, 
anticancer agents, and immunosuppressants. However, discovery efforts were greatly 
reduced towards the end of the 20th century because the same most abundant natural 
products were being “rediscovered” in bioactivity-based screens. As a result, natural product 
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discovery efforts experienced largely diminishing returns. In the post-genomic era, natural 
product research has not only gained renewed interest, but has also undergone dramatic 
transformations propelled by advanced sequencing technologies and genomic tools. 
Genomics has revealed the potential of microbes to produce more natural products than 
previously thought, providing a method to circumvent the problems of rediscovery. The 
workflow of genomics-guided discovery is depicted in Figure 1 using Streptomyces 
clavuligerus as an example, the genome of which contains more than 40 putative 
biosynthetic gene clusters [1].
Genomics-guided discovery of natural products is likely to have profound impacts in 
multiple fields. While natural products remain among the most promising drug leads for 
many contemporary diseases, their importance and applications are becoming increasingly 
recognized in the fields of synthetic biology, chemical ecology and microbiology. Enzymes 
involved in secondary metabolism catalyze a diverse set of reactions that can be evolved and 
utilized in synthetic biology. Natural products themselves play important roles in mediating 
microbe-microbe interactions, host-microbe interactions and influencing disease, growth and 
development. Structural and mode of action studies of these compounds hold great promise 
for advancing our understanding of these processes.
While elucidating the genes involved in the biosynthesis of these molecules is a daunting 
task, it is aided by the tendency of natural product biosynthetic genes to “cluster” within the 
genome. Genes involved in the synthesis of a single natural product are generally found in 
the same genetic locus. Multiple challenges need to be overcome to link these clusters to 
chemical compounds. First, many “orphan” gene clusters either do not express in laboratory 
conditions, or at levels too low for product detection. Second, many natural products come 
from bacteria that are difficult to grow or manipulate, including numerous “unculturable” 
microbes from the human microbiome and environmental sources. Third, natural product 
gene clusters can reach over 100 kb in size, especially those that involve the assembly line-
like non-ribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs), further 
increasing the difficulty of genetic manipulation. Finally, identification and structural 
characterization remains a low-throughput effort that requires both specialized skills and 
intensive efforts.
The development of new technologies that allow for the facile and efficient connection of 
genetic information to secondary metabolites is crucial to modern discovery efforts. As a 
result, a number of tools have been developed and implemented to activate orphan gene 
clusters, such as mutagenesis, modification of regulatory elements, ribosome engineering, 
stimulation with environmental factors, and interspecies interactions [4]. These methods 
have led to the discovery of a number of new natural products and the readers are referred to 
several of excellent reviews for more details [4–8]. In this review, rather than providing a 
comprehensive review of tools for natural product discovery, we have chosen to focus on 
recent developments in direct capture technologies for the heterologous production of 
natural products. These technologies take advantage of well-characterized genetic systems, 
bypass the need for culturing and manipulating native producers, and have potentially broad 
applications and high-throughput capacity.
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2. OVERALL CONCEPT OF DIRECT CAPTURE
Direct capture utilizes homologous recombination to isolate gene clusters from genomic 
DNA in a single step for later heterologous expression. Homologous recombination based 
techniques have emerged as powerful tools for genetic manipulations. This strength is 
evidenced from both the yeast knockout collection and the Escherichia coli Keio collection, 
both generated by homologous recombination [9–10]. Direct capture methods utilize this 
approach to manipulate large DNA molecules in a single step. Two main strategies have 
emerged in direct capture. The first utilizes the model organism Escherichia coli and phage 
recombination (λ Red/ET Recombination) similar to that in the construction of the Keio 
collection. The second takes advantage of the endogenous homologous recombination 
machinery in Saccharomyces cerevisiae (transformation-associated recombination) as in the 
yeast knockout collection [9–10]. The principles and applications of both strategies will be 
discussed in this review.
In both techniques, a capture vector is designed with arms that are homologous to the 
boundaries of the target gene cluster. The “capture host,” either E. coli or S. cerevisiae, is 
then co-transformed with the linearized vector and donor DNA where the target gene cluster 
resides. Homologous recombination results in the capture of the target cluster in the vector, 
which can be readily transferred to a heterologous host for compound production (Fig. 2). In 
addition to identifying new natural products, direct capture establishes a direct link between 
DNA and small molecules. In a way that the central dogma of molecular biology connects 
genes to proteins, we can now connect sets of genes to compounds [11]. This knowledge and 
understanding will help to inform future discovery efforts.
3. METHODOLOGIES
3.1 Natural Product Gene Cluster Identification and Prediction
The first step of genomics-guided natural product discovery is to identify novel natural 
product gene clusters from genome sequences. This effort has been accelerated by recent 
developments in bioinformatics and automation. A number of software platforms, notably 
antiSMASH, Cluster-finder, and SMURF, have been developed to identify genes likely 
involved in secondary metabolism using Hidden Markov Models [2, 12–13]. Some of these 
searches take advantage of the modular nature of PKS and NRPS assembly lines, as well as 
the individual biosynthetic domains within, to predict structural elements of the gene 
cluster’s product [14–17]. Such in silico structure predictions have enabled the recent 
identification of the novel cyclic lipopeptide orfamide A, as well as the pentapeptide 
precursor to nocardicin A [18–20].
Determining the boundaries of the cluster remains less straightforward than structural 
prediction of the core molecule. If the predicted boundaries are too narrow, important 
biosynthetic genes may be left out. Conversely, if the boundary predictions are too wide, in 
addition to increasing the difficulty of understanding the pathway, unrelated clusters may be 
grouped together as “hybrid” clusters. In an effort to combat this, many bioinformatics 
genome mining platforms use a training set to optimize cluster boundary predictions. When 
assigning genes to either the same or separate clusters, they may take into account the 
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number of non-secondary metabolism genes between potential boundaries, the total number 
of genes, and the number of nucleotides between genes [18–20]. Manual inspection of 
cluster boundaries still has utility, especially when the cluster is present in multiple 
sequenced organisms. The synteny between related clusters can aid in identifying the genes 
that are part of the cluster, and those that are unrelated [21].
Even when cluster boundary predictions are accurately made, a number of cases exist in 
which natural product gene clusters do not follow the simple ‘rule’ of clustering and instead 
involve additional genes at distal loci. In the biosynthesis of actinorhodin by Streptomyces 
coelicolor A3(2), a malonyltransferase essential in primary metabolism is necessary for 
biosynthesis, and is located 2.8 Mb from the actinorhodin gene cluster [22]. A similar 
situation is seen in the biosynthesis of the histone deacetylase inhibitors FK228 and the 
thailandepsins [23–24]. In all three of these clusters, the analogous gene for secondary 
metabolism was absent, and successful compound production required either the 
identification of the responsible gene from elsewhere in the genome, or the utilization of a 
heterologous host capable of supplying its own analogous gene. In the case of the 
siderophores erythrochelin and rhodochelin, two and three distinct gene clusters are needed, 
respectively, for biosynthesis of the natural product. The phytotoxin coronatine is composed 
of two separate moieties, coronafacic acid and coronamic acid, and in many strains of 
Pseudomonas syringae, the genes for both are within a single cluster. However, in P. 
syringae pv. tomato DC3000, the genes for each moiety are separated by 26 kb [25]. In a 
similar case, while the biosynthesis of the antibiotic congocidine is limited to a single gene 
cluster in Streptomyces ambofaciens, its biosynthesis in Streptomyces netropsis, as well as 
that of two other pyrrolamides, requires two gene clusters separated by at least 58 kb [26]. 
These cases are only a small subset of known natural product bio-synthetic pathways, but 
illustrate the concept that even the best gene cluster prediction software may not reveal all 
essential genes for a given product.
Ultimately, there is no single correct method to accurately identify the boundaries of a gene 
cluster. However, the power of bioinformatics platforms and the number of microbial 
genomes available have greatly simplified the process [27]. Based on the examples described 
later in this review, the approach of including extra, unrelated genes within the predicted 
bounds of the cluster has allowed the isolation of a number of compounds, with no observed 
impacts (neither positive nor negative) on their production.
3.2.1. “Recombineering” in E. coli: λ Red/ET Recombination—Two parallel 
systems have been developed from phage recombination for use in E. coli as recombineering 
techniques. One system is derived from λ prophage, comprising the enzymes Redα, Redβ, 
and Redγ and is known as the “λ Red” system [28]. The analogous system from Rac 
prophage involves the enzymes RecE and RecT, known as “ET recombination” [29–30]. The 
pairs RecET and Redαβ are functionally equivalent. RecE and Redα are 5′ to 3′ 
exonucleases. RecT and Redβ are ssDNA-binding proteins, which facilitate complementary 
DNA strand annealing [31]. Redγ on the other hand, has no counterpart in the RecET 
system. The function of Redγ is to inhibit the activities of RecBCD, which function as 
dsDNA and ssDNA exonucleases and helicases [28, 32–33].
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Both linear and circular DNA molecules have been successfully recombined with introduced 
linear DNA by phage recombination. The λ Red system works efficiently on circular 
substrates in a linear plus circular homologous recombination (LCHR) fashion. In contrast, 
the ET recombination system shows proficiency at linear plus linear homologous 
recombination (LLHR) [34]. It should be noted that the introduction of Redγ to ET 
recombination enhances the system, presumably due to protection of the introduced DNA 
from RecBCD’s nuclease activities [32, 34]. Studies on LCHR and LLHR have revealed that 
they are mechanistically distinct. Essentially, LCHR is DNA replication dependent while 
LLHR was confirmed to be replication independent [34–35]. The details on the mechanism 
of phage recombination have been recently reviewed [32, 35–36].
The application of ET recombination in direct capture was first described in 2000, involving 
the capture of a large stretch of DNA (> 20 kb) from a BAC into a linearized plasmid 
(LLHR) [30]. In the same study, the capture of smaller targets (<5 kb) was also reported, by 
transforming an ET recombination proficient E. coli strain with genomic DNA fragments, in 
a linear plus linear fashion [30]. Fast-forward a decade, ET recombination was used in the 
capture of the 19 kb syringolin gene cluster from genomic DNA of Pseudomonas syringae 
(Fig. 2) [37]. The direct capture of this cluster from P. syringae allowed for its heterologous 
expression in E. coli and subsequent characterization of additional members of the 
syringolins, a family of hybrid PKS-NRPS natural products (1) (Fig. 3) [37]. In another 
study, full length RecE and RecT were used in the capture of the hybrid PKS-NRPS 
luminmycin cluster (2) and the NRPS luminmide cluster resulting in their heterologous 
production and characterization [34].
The λ Red system was also employed to successfully capture 20 natural product gene 
clusters and heterologously express them in engineered strains of Streptomyces avermitilis 
[38]. Although the λ Red system is less efficient than ET recombination for linear plus 
linear applications, it was successfully used in this study to capture gene clusters from 
linearized cosmids. The production of several clinically relevant and biologically important 
natural products was reported, including streptomycin (Streptomyces griseus), erythromycin 
A (Sacchropolyspora erythraea), cephamycin C (Streptomyces clavuligerus), holomycin (3) 
(S. clavuligerus), clavulanic acid (4) (S. clavuligerus), rebeccamycin (Lechevalieria 
aerocolonigenes), novobiocin (Streptomyces anulatus) and chloramphenicol (Streptomyces 
venezuelae) [38]. For many compounds, production was enhanced in comparison to the 
native producer. Streptomycin was improved relative to S. griseus by 2- to 2.5-fold. More 
dramatically, production of holomycin was increased from less than 0.2 mg/L in the 
wildtype producer to 8 mg/L in the heterologous expression strain [38–39]. In addition to 
improving production, the study was also able to activate a cryptic gene cluster. Although 
the S. clavuligerus genome encodes a gene cluster for pholipomycin, the strain has not been 
shown to produce such a compound. When this cluster was expressed in a derivative of S. 
avermitilis, a yield of 20 mg/L pholipomycin was observed [38]. This study demonstrated 
the versatility of the λ Red/ET recombination systems in capturing natural products of 
different classes and origins, while greatly enhancing production levels.
3.2.2. Expansion of Phage Recombination into Other Genera—Recently, the 
generation of a recombineering system in the related genera, Photorhabdus and 
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Xenorhabdus was reported [40]. Each harbors genes analogous to Red α, β, and γ, which 
have been repurposed for gene cluster activation by promoter exchange. The study 
introduced a tetracycline inducible promoter, using the analogous λ Red system, upstream 
of a cryptic chromosomal NRPS gene cluster to activate expression, resulting in the 
production of nonribosomal peptides ranging from a heptapeptide to a nonapeptide in the 
native bacterium [40]. Although this study did not involve direct capture of gene clusters 
from genomic DNA, it expanded on the phage homologous recombination system with 
potentially broad implications. The identification and functionalization of λ Red/ET 
recombination systems in other bacterial strains, especially those of the Streptomyces genus, 
may allow for the activation of cryptic gene clusters in their native hosts and bypass the need 
for heterologous hosts.
3.3.1. Yeast Transformation-Associated Recombination—Homologous 
recombination has been utilized in yeast for decades for the purposes of cloning and 
modifying yeast strains. More recently, the potential of the highly efficient machinery 
responsible for recombination has been realized towards more complex efforts, including 
assembling the first synthetic genome and the generation of large libraries for N-hybrid 
assays [41–42]. The most notable technique of this nature is transformation-associated 
recombination (TAR). TAR enables the capture of large genetic elements from a target 
organism into a selectable vector through a single transformation step. By co-transforming 
the target genomic DNA with a yeast compatible vector that contains “hooks” homologous 
to the ends of a target region, DNA sequences as large as 250 kb can be captured and 
isolated for heterologous gene cluster expression.
A 3-organism strategy is generally employed for TAR (Fig. 2). First, the cluster is captured 
by TAR in a strain of S. cerevisiae. Next, the captured cluster is transferred to an E. coli 
strain for vector amplification, sequencing, and any necessary modifications. Finally, the 
cluster is transferred to a heterologous host for gene cluster expression and compound 
production.
While TAR was first described in 1996, the first natural product gene cluster was captured 
and reported in 2010 [43–44]. In this work, the authors captured the 56 kb colibactin gene 
cluster from Citrobacter koseri using genomic DNA, as well as two additional 
uncharacterized PKS and NRPS clusters from eDNA cosmid libraries [43]. The eDNA 
approach is particularly interesting because it leveraged a core strength of TAR, the single-
step capture of large genetic elements, to complement a relative weakness of cosmid 
libraries, the 40–50 kb insert limitation. In a more symbolic sense, this study also bridged 
the gap between existing techniques for natural product discovery (cosmid libraries) and new 
(TAR) techniques for natural product discovery. The first heterologous expression of a 
natural product cluster using TAR was reported later that year, with the capture and 
expression of a number of fluostatins from environmental DNA (eDNA) clusters in a 
Streptomyces albus host [45]. The polyketides arixanthomycin A-C were also discovered 
using this strategy, yielding compounds with cytotoxicity in the sub-micromolar range [46].
Bioinformatic analysis identified a hybrid fatty acid/NRPS cluster in a Saccharomonospora 
spp. that was anticipated to synthesize a halogenated daptomycin analog. Upon capture of 
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the cluster by TAR and expression in S. albus, taromycin A (5) was discovered and 
characterized. This study was the first to directly capture and express a natural product gene 
cluster from genomic DNA using TAR. However, initial attempts of heterologous expression 
using the captured cluster were unsuccessful, yielding no compound. In an effort to remove 
negative regulators within the cluster bounds, predicted regulatory elements were knocked 
out by a yeast PCR-targeting strategy (analogous to λ Red PCR-targeting), which resulted in 
the production of taromycin A by S. coelicolor M1146 [47–48].
TAR was combined with λ Red to enhance heterologous expression when capturing the 
bromoalterochromide cluster from Pseudoalteromonas piscicida. Initial production of 
alterochromides was 60-fold lower than the native producer. To improve this, λ Red was 
used to transfer the whole cluster from the initial capture vector into pETDuet-1. This placed 
the entire cluster downstream of the T7 promoter for inducible expression in E. coli, 
resulting in a 20-fold increase in bromoalterochromide (6) production relative to the 
endogenous promoter. According to the authors, at 34 kb, it was the largest NRPS cluster to 
be expressed in E. coli in a singular construct to date [49].
A similar strategy was used to investigate the biosynthesis of amicoumacins (7) from the 
marine isolate, Bacillus subtilis 1779. Following capture of the cluster by TAR, λ Red was 
used to knockout a peptidase gene to confirm its function which revealed the prodrug 
preamicoumacin when the cluster was expressed in Bacillus subtilis 168. Perhaps most 
notably, this was the first reported heterologous expression of natural products in B. subtilis 
using direct cloning, facilitated by TAR [50].
TAR capture strategies for eDNA derived clusters have also begun implementing 
engineering efforts as well. A cluster predicted to generate an indolotryptoline product was 
captured from eDNA by TAR, but no product formation was detected in the heterologous 
host S. albus. Using yeast PCR-targeting, all of the native promoters were replaced with 
constitutive promoters and yeast selection markers. This enabled the discovery of 
lazaramide, which displays cytotoxicity in the low nanomolar range [51].
As with any technology, TAR cloning has its drawbacks. While the colibactin gene cluster 
was amongst the first natural product gene clusters captured from genomic DNA, this 
attempt was unsuccessful in producing colibactin. Successful production of colibactin by a 
TAR strategy only came after an independent effort five years later [52]. Although TAR is 
able to capture clusters efficiently, some remain intractable for heterologous production. For 
example, the cluster for nataxazole, a cytotoxic benzoxazole, was captured by TAR but 
expression of the cluster caused significant growth inhibition in heterologous hosts. 
Moreover, some hosts could not be transformed due to the cytotoxicity of nataxazole 
pathway intermediates [53].
Unlike the phage-based systems, which can be performed in E. coli alone, TAR requires the 
use of S. cerevisiae. While this microbe is a model system for many fields, it is often a new 
strain for many natural products-oriented labs. As such, techniques for culturing, 
transforming, and genetically manipulating yeast may require significant investments for 
labs lacking experience with fungi or eukaryotes. Vector construction is also more complex 
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in TAR, as yeast replication elements and selection markers must be included in addition to 
the E. coli and heterologous host elements. The exact mechanisms of TAR are also 
unknown, and there may be limitations to the technology that have not been identified yet 
[54]. Additionally, TAR remains to be commercialized, and therefore does not yet benefit 
from the support that many established technologies have.
The capture of a gene cluster is often in practice not sufficient for many targets. Therefore, a 
number of techniques have been developed to refactor the regulatory systems controlling the 
cluster, successfully boosting gene expression and compound production. Another 
perceivable challenge is the ability of heterologous hosts to both accept and stably maintain 
large DNA molecules, even if very large genetic elements can be captured. However, in the 
current 3-organism format involving S. cerevisiae, E. coli, and the heterologous production 
host, TAR shows great potential for the study of natural products.
3.3.2. DNA Assembler—Like TAR, DNA assembler harnesses the homologous 
recombination power of yeast using short homology regions to stitch together DNA 
sequences (Fig. 4)[55]. While TAR focuses on capturing a natively organized gene cluster, 
DNA assembler refactors the entire cluster from fragments [56–57]. Each gene in the cluster 
is individually amplified by PCR, then joined to a promoter sequence and terminator 
sequence by overlap extension PCR, such that each preceding construct bears homology to 
the proceeding construct. These promoter-gene-terminator amplicons and linearized vector 
are then co-transformed into yeast and assembled into a refactored gene cluster by 
homologous recombination (Fig. 4)[55].
Following a proof-of-concept study in which the pathways for D-xylose utilization and 
zeaxanthin biosynthesis were refactored, DNA assembler was used to reconstruct the 
spectinabilin pathway from Streptomyces orinoci [55]. The design of the reconstructed 
cluster omitted repressor norD and incorporated validated strong promoters ahead of each 
gene for constitutive expression. As a result, spectinabilin (8) was produced in the 
heterologous host Streptomyces lividans. The refactoring of this known pathway represented 
the first application of DNA assembler towards secondary metabolites [57], which was later 
applied towards the characterization of three novel polycyclic tetramic acid natural products 
[56].
3.4. Heterologous Host Considerations
While it may seem a simple step, the selection of an appropriate host for heterologous 
expression is critical. The optimal expression strain is generally closely related to, and often 
in the same genus as, the strain the target cluster was captured from. If a closely related 
strain cannot be used, it is important to choose a host that is similar in codon usage and 
regulation of gene expression to the native host. Another important consideration is the 
availability of biosynthetic precursors, such as amino acids for nonribosomal peptides, and 
acyl-CoAs for polyketides. Finally, the host strain should be both relatively easy to culture 
and capable of accepting foreign DNA. Since the Streptomyces genus produces the lion’s 
share of natural products, several engineered strains have been developed and are already 
utilized for the production of natural products. These include several strains of S. coelicolor 
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A3(2) and S. avermitilis [39, 58]. These strains have been engineered to remove endogenous 
secondary metabolite gene clusters in order to simplify the identification of heterologously 
produced compounds, promote carbon and nitrogen flux towards desired pathways, and to 
increase precursor availability [39, 58]. Additional improvements of the S. coelicolor A3(2) 
derived expression hosts were achieved by the incorporation of mutations in RNA 
polymerase and ribosomal protein S12, which have been shown to increase secondary 
metabolite production [58]. These engineered strains of S. avermitilis and S. coelicolor are 
suitable heterologous hosts for gene clusters captured by TAR or the phage recombination 
systems in addition to other strains commonly used including S. lividans and S. albus.
4. COMPARISON OF DIRECT CAPTURE WITH TRADITIONAL NATURAL 
PRODUCT CLONING TECHNIQUES
Traditional methods for studying natural product gene clusters have involved the creation of 
genomic libraries in the form of cosmids and bacterial artificial chromosomes (BACs). 
Forming these libraries is a well-established process that has been commercialized for use in 
many fields. Most laboratories are equipped to create, maintain, and implement these DNA 
libraries. Creating a library can still be a laborious and complex process, as it involves 
multiple DNA manipulation steps, phage packaging and the screening of thousands of 
clones, but established protocols exist for each phase. Since cosmid and BAC inserts are 
generated through enzymatic digest or shearing genomic DNA, there is no sequence 
specificity as to which fragments are incorporated into each vector, and clusters may be 
fragmented across multiple vectors [59]. Commercial kits are also not directly transferable 
to heterologous hosts. The backbones require retrofitting with replication and selection 
elements for maintenance in host strains, as well as transfer elements to facilitate movement 
of the cluster into heterologous hosts [48].
Direct capture technologies have several clear benefits when capturing gene clusters for 
heterologous expression. The targeted approach focuses on only the selected cluster of 
interest, and captures the whole cluster in a single step. In both phage-based systems and 
TAR, the capture vector can be pre-equipped with elements necessary for heterologous 
expression, which dramatically streamlines the cloning process. Construction of a cluster-
specific capture vector is also relatively straightforward in both direct capture techniques. 
For the phage-based systems, the homology required is on the scale of 40 bp, which can be 
conveniently synthesized as a 5′ addition to a PCR oligonucleotide [48]. Similarly, the 
homology required for the TAR system requires less than 1 kb (documented down to less 
than 60 bp), which eliminates the need for long PCRs to generate homology arms (Fig. 2) 
[60].
Phage-based recombination is well studied and widely implemented, but its use is often 
limited to capture gene clusters less than 40 kb in size. TAR, by comparison, is able to 
overcome these size limitations, but requires a much more specialized approach. Unlike the 
widely utilized E. coli, S. cerevisiae is less routinely used as a tool for many natural products 
laboratories. Protocols for TAR are still being developed, and the methodologies in design 
and implementation vary between labs.
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In many ways, library methods and directed capture are complementary approaches. A 
cosmid/BAC library can be generated to capture an entire genome or metagenome, and 
direct capture can be then used to assemble the desired cluster in a single vector, as 
demonstrated by the capture of numerous clusters from eDNA libraries, as noted earlier [43, 
45–46, 51, 61].
Ultimately, direct capture takes advantage of the growing wealth of sequencing information, 
enabling a true genomics-guided approach. However, cosmid/BAC libraries remain useful 
technologies when sequencing information is unavailable or low-resolution.
5. SUMMARY
In this review we have described how these homologous recombination systems have been 
applied as a form of direct capture for the study of secondary metabolites since 2010. These 
efforts not only led to heterologous production of compounds of interest, but also enabled 
the discovery of novel compounds.
As of this writing, more successful TAR studies have been reported than the combined λ 
Red/ET recombination efforts. Although direct capture has simplified gene cluster isolation, 
further manipulations of the cluster are still beneficial and sometime necessary for 
compound production. Repressor deletions and promoter exchange are just two possible 
modifications that are afforded by homologous recombination. Both the E. coli based system 
and the S. cerevisiae system have seen success in natural product gene cluster capture; 
however, TAR has been used more successfully for cluster capture while phage 
recombination is more readily used for cluster modification following capture.
6. OUTLOOK – RECENT INNOVATIONS AND PIONEERING THE FUTURE OF 
NATURAL PRODUCTS
Homologous recombination based techniques hold promise for the future of natural product 
discovery and for unlocking cryptic gene clusters. The applications of TAR in the capture of 
gene clusters from environmental DNA have allowed for analysis of clusters that are natively 
harbored by ‘unculturable’ bacteria. Future applications of TAR might directly capture gene 
clusters from metagenomic DNA, without the need of building cosmid libraries first. In 
either case, TAR has great potential as a technology to discover novel compounds from 
environmental bacteria whose genes have been previously deemed inaccessible.
Besides phage recombination in E. coli and TAR in yeast, Bacillus subtilis is another model 
platform that may serve as a suitable vector for the capture of natural product gene clusters. 
The 4.2 Mb B. subtilis 168 genome is known as the B. subtilis genome-based manipulation 
(BGM) vector [62]. The BGM vector has been used in the reconstruction of an entire 3.5 Mb 
genome from many individual and overlapping pieces, in a fashion called the domino 
method or “domino cloning” [62–63]. Furthermore, B. subtilis has a high homologous 
recombination rate and natural competence, making it an ideal host for direct capture [63–
65]. B. subtilis has been used as an effective host for the heterologous expression of natural 
product gene clusters, including the expression of an amicoumacin cluster captured directly 
Chan et al. Page 10
Curr Top Med Chem. Author manuscript; available in PMC 2017 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
by TAR as well as the nisin, rhizocticins, and polymyxin clusters captured indirectly [50, 
66–68]. Despite these advantages, B. subtilis has yet to be exploited for direct capture 
applications to discover new natural products from cryptic gene clusters. B. subtilis has the 
potential to become a powerful tool for the capture of natural product gene clusters in a 
similar fashion to phage recombination and TAR, especially for AT-rich bacteria [61–62].
We anticipate that emerging genomic editing tools will further the discovery and 
heterologous production of natural products. Recently, two genome modification techniques 
have been developed for the Streptomyces genus, including the SceI meganuclease of S. 
cerevisiae and the CRISPR system, which function by creating lethal double stranded breaks 
[69–72]. A homology directed repair cassette facilitates the repair of these breaks and avoids 
lethality. Deletions and insertions of individual genes are well-documented but using either 
system to insert an entire cluster remains to be examined. In principle, smaller gene clusters 
would be better tolerated. The homology directed repair cassettes containing the gene 
clusters of interest could be sourced from a TAR or phage-based capture system. The 
combination of techniques will likely provide opportunities for multiplexing, dramatically 
accelerating the rate of genomics-guided discovery of natural products.
Although all of these techniques aim to make cryptic gene clusters more readily accessible 
there is no singular recipe for success; each cluster and system can be considered ‘unique,’ 
and it is likely that some cryptic clusters await further technological developments for their 
unlocking. The unprecedented ability to capture large genetic elements in a targeted 
approach, combined with recent methods to modify these clusters, has the potential to 
change the way natural product gene clusters are studied. These techniques may open up 
new branches in the study of microbial natural products and allow researchers to investigate 
clusters previously thought inaccessible, either due to degree of complexity or from poor 
understanding of the native organism.
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Fig. (1). 
Applications of genome mining and heterologous expression towards natural products 
discovery. A) Bioinformatic analysis of microbial genomes can identify natural product gene 
clusters, such as that of holomycin. Gene clusters were identified by antiSMASH analysis 
[2], and visualized with Circos [3]. B) Heterologous expression of these cultures facilitates 
the elucidation of their products, which can be used towards a variety of scientific and 
medicinal efforts.
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Fig. (2). 
Comparisons of steps in phage recombination and transformation-associated recombination 
for direct capture. (i) The generalized steps in direct capture and heterologous natural 
product gene cluster expression. (ii) The specific steps in direct capture by phage 
recombination. (iii) Differences of transformation-associated recombination from phage 
recombination.
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Fig. (3). 
Selected structures of compounds directly captured and heterologously produced. (1) 
syringolin A, (2) luminmycin A, (3) holomycin, (4) clavulanic acid, (5) taromycin A, (6) 
bromoalterochromide A, (7) amicoumacin A, (8) spectinabilin.
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Fig. (4). 
DNA assembler scheme. (i) DNA fragments are amplified to bear homology to each 
proceeding and preceding molecule (color blocks). The vector is also linearized and 
designed with homology to both ends of the cluster. (ii) S. cerevisiae is transformed with the 
DNA fragments whereupon homologous recombination assembles the cluster as in (iii).
Chan et al. Page 19
Curr Top Med Chem. Author manuscript; available in PMC 2017 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
